Excipient Interaction with Cetylpyridinium Chloride Activity in Tablet Based Lozenges

R. Michael E. Richards1, James Z. Xing1, Kirsty M. B. Mackay1
1School of Pharmacy, The Robert Gordon University, Aberdeen, United Kingdom

Tóm tắt

Purpose. The purpose of the investigation was to determine the effect of tablet excipients on the activity of cetylpyridinium chloride (CPC) and the relative interaction between excipients and CPC. Methods. An analytical assay was developed to evaluate the interaction between CPC and the excipients. In vivo activity was investigated using six volunteers by determining the reduction in colony forming units recoverable from the oropharynx after sucking each proprietary lozenge separately on different days. In vitro determinations investigated the relative antimicrobial activity of aqueous solutions of the lozenges and, the effect of pH and tablet base excipients on that activity against Staphylococcus aureus, Streptococcus pyogenes and Candida albicans. Results. Both in vivo and in vitro results showed that the tablet based lozenges had markedly reduced antimicrobial activities compared with previous results with a candy based lozenge (in vivo and in vitro) or the same concentration of aqueous CPC (in vitro}. Magnesium stearate suspensions in CPC 250 µg/ml indicated that magnesium stearate adsorbed CPC and at 0.4% lozenge weight and above significantly reduced the antimicrobial activity of CPC 250 µg/ml. Conclusions. The reduced activity of CPC in tablet based lozenges resulted from a decreased availability of CPC in solution due to an adsorption of CPC on magnesium stearate. To avoid this reduction in activity tablet based lozenges containing CPC 250 µg/ml, or similar concentrations, plus magnesium stearate should contain not more than 0.3% w/w lozenge weight of the lubricant.

Từ khóa


Tài liệu tham khảo

R. M. E. Richards. Inhibitory activity of lozenges on oral bacteria. Pharmacotherapy. 8:52, (1988).

R. M. E. Richards and G. Cowie. Evaluation of the number of viable bacteria recovered from the mouth after sucking lozenges. Pharm. J. 241 (Practice Res. Suppl.): R26–27, (1988).

R. M. E. Richards, G. Cowie and G. J. McCague. In vivo investigations of the antibacterial activity of lozenges and mouthwashes on the aerobic bacterial flora of the mouth and throat. Pharm. J. 242:659–663, (1989).

R. M. E. Richards and L. M. Rochester. Influence of formulation on the effectiveness of antimicrobials in the oropharynx. 49th. FIP, Int. Cong. Abstracts, Abstr. 120, 1989.

R. M. E. Richards and D. K. L. Xing. In vitro evaluation of the antimicrobial activities of selected lozenges. J. Pharm. Sci. 82:1218–1220, (1993).

R. M. E. Richards, J. Z. Xing and L. Weir. The effect of formulation on the antimicrobial activity of cetylpyridinium chloride in candy based lozenges. Pharm. Res. 13:581–585, (1996).

Cetylpyridinium chloride, In The United States Pharmacopeia XXII. United States Pharmacopeial Convention, Inc., United States, 1990, pp.268.

Magnesium stearate, In British Pharmacopoeia. London HMSO, United Kingdom, 1993, pp. 397–398.

J. Murdoch and J. A. Barnes. Statistical Tables, Macmillan Education Ltd., London, 1991.

P. R. Nelson. Design and analysis of experiments. In H. M. Wadsworth, Jr. (ed.), Handbook of Statistical Methods for Engineers and Scientists. McGraw-Hill Publishing Company, United States, 1990, pp. 14.21-14.23.

G. Levy and R. H. Gumtow. Effect of certain formulation factors on dissolution rate of the active ingredient III: tablet lubricants. J. Pharm. Sci. 52:1139–1144, (1963).

H. C. Caldwell. Dissolution of lithium and magnesium from lithium carbonate capsules containing magnesium stearate. J. Pharm. Sci. 63:770–773, (1972).

M. S. H. Hussain, P. York and P. Timmins. Effect of commercial and high purity magnesium on in-vitro dissolution of paracetamol DC tablets. Int. J. Pharm. 78:203–207, (1992).

R. A. Nash. Sorbitol. In A. Wade and P. J. Weller (ed.) Handbook of Pharmaceutical Excipients, (2nd. Ed.) The Pharmaceutical Press, London, 1986, pp.477-480.

H. E. C. Worthington and P. M. Olinger. Xylitol. In A. Wade and P. J. Weller (ed.) Handbook of Pharmaceutical Excipients, (2nd. Ed.) The Pharmaceutical Press, London, 1986, pp.564-567.